Evidence map›Paper›PMID 20610709›Full record

ArticleJournal of virology2010

JC virus latency in the brain and extraneural organs of patients with and without progressive multifocal leukoencephalopathy.

Chen S Tan, Laura C Ellis, Christian Wüthrich, Long Ngo, Thomas A Broge, Jenny Saint-Aubyn, Janice S Miller, Igor J Koralnik

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 1 pooled it
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 1 synthesis or guideline pooled it, 120 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Diagnosis and Treatment of Progressive Multifocal Leukoencephalopathy Associated with Multiple Sclerosis Therapies.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2017
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Chen S TanDivision of Infectious Disease, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
Laura C Ellis
Christian Wüthrich
Long Ngo
Thomas A Broge
Jenny Saint-Aubyn
Janice S Miller
Igor J Koralnik
Global Viral · USBeth Israel Deaconess Medical Center · US

Funding

The impact of HIV viral diversity and cellular immunity on HIV pathogenesisP30AI060354 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI ROBERT A. PARKER · 2004 to 2026
$94.4M
The Manahattan HIV Brain BankR24MH059724 · NIMH · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI MORGELLO, SUSAN · 1998 to 2007
$15.4M
NEUROAIDS TISSUE NETWORKR24MH059745 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GRANT, IGOR · 1998 to 2007
$13.2M
INFECTIOUS DISEASE AND BASIC MICROBIOLOGICAL MECHANISMST32AI007061 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Marcia B Goldberg · 1985 to 2026
$12.1M
National Neurological AIDS Bank (NNAB)R24NS038841 · NINDS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SINGER, ELYSE J · 1998 to 2007
$12.0M
MOLECULAR BASIS OF VIRAL INFECTIVITYT32AI007245 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI Aaron Gregory Schmidt · 1985 to 2026
$11.3M
Role of Inflammation in Progressive Multifocal LeukoencephalopathyR01NS047029 · NINDS · RUSH UNIVERSITY MEDICAL CENTER · PI KORALNIK, IGOR J. · 2004 to 2018
$6.4M
CELLULAR IMMUNITY TO JC VIRUS IN AIDS ASSOCIATED PMLR01NS041198 · NINDS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI KORALNIK, IGOR J. · 2001 to 2009
$3.3M
TEXAS REPOSITORY FOR AIDS NEUROPATHOGENESIS RESEARCHR24MH059656 · NIMH · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI GELMAN, BENJAMIN B. · 1998 to 2001
$2.7M
JC Virus Primary Infection, Latency, and ReactivationK08NS064215 · NINDS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI TAN, CHEN SABRINA · 2009 to 2013
$865k
Translational applications of Progressive Multifocal Leukoencephalopathy studiesK24NS060950 · NINDS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI KORALNIK, IGOR J. · 2008 to 2012
$707k
NIAID NIH HHS P30 AI060354NIAID NIH HHS P30 AI60354NIAID NIH HHS T32 AI007061NIAID NIH HHS T32 AI007245NIAID NIH HHS T32 AI007245-26NIAID NIH HHS T32 AI007245-27NIMH NIH HHS R24 MH059724NIMH NIH HHS R24 MH059745NIMH NIH HHS R24MH59656NIMH NIH HHS R24MH59724NIMH NIH HHS R24MH59745NINDS NIH HHS K08 NS064215NINDS NIH HHS K08 NS 064215-01A1NINDS NIH HHS K24 NS 060950NINDS NIH HHS K24 NS060950NINDS NIH HHS R01 NS 041198NINDS NIH HHS R01 NS041198NINDS NIH HHS R01 NS 047029NINDS NIH HHS R01 NS047029NINDS NIH HHS R24 NS038841NINDS NIH HHS R24NS38841
6 · The paper itself

Abstract

JC virus (JCV) is latent in the kidneys and lymphoid organs of healthy individuals, and its reactivation in the context of immunosuppression may lead to progressive multifocal leukoencephalopathy (PML). Whether JCV is present in the brains or other organs of healthy people and in immunosuppressed patients without PML has been a matter of debate. We detected JCV large T DNA by quantitative PCR of archival brain samples of 9/24 (38%) HIV-positive PML patients, 5/18 (28%) HIV-positive individuals, and 5/19 (26%) HIV-negative individuals. In the same samples, we detected JCV regulatory region DNA by nested PCR in 6/19 (32%) HIV-positive PML patients, 2/11 (18%) HIV-positive individuals, and 3/17 (18%) HIV-negative individuals. In addition, JCV DNA was detected in some spleen, lymph node, bone, and kidney samples from the same groups. In situ hybridization data confirmed the presence of JCV DNA in the brains of patients without PML. However, JCV proteins (VP1 or T antigen) were detected mainly in the brains of 23/24 HIV-positive PML patients, in only a few kidney samples of HIV-positive patients, with or without PML, and rarely in the bones of HIV-positive patients with PML. JCV proteins were not detected in the spleen or lymph nodes in any study group. Furthermore, analysis of the JCV regulatory region sequences showed both rearranged and archetype forms in brain and extraneural organs in all three study groups. Regulatory regions contained increased variations of rearrangements correlating with immunosuppression. These results provide evidence of JCV latency in the brain prior to severe immunosuppression and suggest new paradigms in JCV latency, compartmentalization, and reactivation.

Indexed as

Virus LatencyBone and BonesBrainDNA, ViralGene RearrangementHumansJC VirusKidneyLymph NodesPolymerase Chain ReactionPolyomavirus InfectionsSpleenViral ProteinsDNA, ViralViral Proteins

Identifiers

PMID20610709
PMCPMC2937633
OpenAlexW2005259841

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.